Drummond, Daryl C.,Kirpotin, Dmitri B.,Kamoun, Walid
申请号：
AU2017232634
公开号：
AU2017232634A1
申请日:
2017.03.16
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
EphA2 targeted doxorubicin generating nano-liposomes are useful in the treatment of EphA2 positive cancer comprising cancer cells expressing over about 3000 EphA2 receptors/cell. Diagnostic methods for identifying EphA2 positive cancer patients and methods of treating identified patients with a Eph-A2 targeted nanoliposome encapsulating a docetaxel prodrug are provided.
